VANDETANIB vs VEDOLIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VANDETANIB vs VEDOLIZUMAB: Safety Overview
| Metric | VANDETANIB | VEDOLIZUMAB |
|---|---|---|
| Total FAERS Reports | 1,159 | 73,857 |
| Deaths Reported | 93 | 3,476 |
| Death Rate | 8.0% | 4.7% |
| Hospitalizations | 363 | 21,677 |
| Average Patient Age | 53.6 yrs | 50.0 yrs |
| % Female Patients | 54.8% | 56.5% |
| FDA Approval Date | Apr 6, 2011 | N/A |
| Manufacturer | Genzyme Corporation | Takeda Pharmaceuticals America, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |